RADIESSE INJECTABLE IMPLANT

Implant, Dermal, For Aesthetic Use

FDA Premarket Approval P050052

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for radiesse. This device is indicated for subdermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds.

DeviceRADIESSE INJECTABLE IMPLANT
Classification NameImplant, Dermal, For Aesthetic Use
Generic NameImplant, Dermal, For Aesthetic Use
ApplicantMERZ NORTH AMERICA, INC
Date Received2005-12-22
Decision Date2006-12-22
Notice Date2007-01-17
PMAP050052
SupplementS
Product CodeLMH
Docket Number07M-0007
Advisory CommitteeGeneral & Plastic Surgery
Expedited ReviewNo
Combination Product No
Applicant Address MERZ NORTH AMERICA, INC 4133 Courtney Road suite 10 franksville, WI 53126
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P050052Original Filing
S142 2022-12-15 30-day Notice
S141
S140 2022-11-01 30-day Notice
S139 2022-11-01 30-day Notice
S138
S137
S136 2022-04-12 135 Review Track For 30-day Notice
S135 2022-04-08 30-day Notice
S134 2022-01-06 30-day Notice
S133
S132 2021-09-21 Special (immediate Track)
S131 2021-02-05 135 Review Track For 30-day Notice
S130 2020-12-23 135 Review Track For 30-day Notice
S129
S128
S127 2020-09-25 30-day Notice
S126 2020-09-18 30-day Notice
S125 2020-09-18 30-day Notice
S124 2020-06-30 30-day Notice
S123
S122 2020-04-21 30-day Notice
S121 2020-04-03 30-day Notice
S120
S119 2019-12-18 Normal 180 Day Track
S118 2019-11-26 30-day Notice
S117
S116
S115 2019-05-16 135 Review Track For 30-day Notice
S114 2019-05-10 30-day Notice
S113 2019-05-09 30-day Notice
S112 2019-05-07 30-day Notice
S111 2019-04-19 30-day Notice
S110 2018-10-15 Normal 180 Day Track No User Fee
S109 2018-06-08 30-day Notice
S108 2018-06-08 30-day Notice
S107
S106 2018-06-06 30-day Notice
S105 2018-04-02 135 Review Track For 30-day Notice
S104 2018-03-26 30-day Notice
S103
S102 2018-01-16 30-day Notice
S101
S100 2017-10-24 30-day Notice
S099 2017-10-19 30-day Notice
S098 2017-10-12 Normal 180 Day Track No User Fee
S097 2017-07-31 30-day Notice
S096 2017-07-17 Normal 180 Day Track No User Fee
S095 2017-06-06 30-day Notice
S094 2017-06-01 30-day Notice
S093 2017-04-07 30-day Notice
S092 2017-04-03 135 Review Track For 30-day Notice
S091 2017-01-18 Normal 180 Day Track No User Fee
S090 2017-01-18 Normal 180 Day Track No User Fee
S089 2016-12-23 30-day Notice
S088 2016-12-06 135 Review Track For 30-day Notice
S087 2016-07-22 30-day Notice
S086 2016-06-13 135 Review Track For 30-day Notice
S085 2016-05-31 30-day Notice
S084 2016-05-31 135 Review Track For 30-day Notice
S083 2016-05-26 30-day Notice
S082 2015-12-22 135 Review Track For 30-day Notice
S081 2015-12-11 Normal 180 Day Track No User Fee
S080 2015-12-11 135 Review Track For 30-day Notice
S079 2015-12-07 135 Review Track For 30-day Notice
S078 2015-12-07 Real-time Process
S077 2015-12-04 135 Review Track For 30-day Notice
S076 2015-12-02 135 Review Track For 30-day Notice
S075 2015-12-01 30-day Notice
S074 2015-10-20 Special (immediate Track)
S073 2015-09-25 135 Review Track For 30-day Notice
S072 2015-09-04 30-day Notice
S071 2015-07-13 Special (immediate Track)
S070 2015-07-02 Normal 180 Day Track No User Fee
S069 2015-07-02 Normal 180 Day Track No User Fee
S068 2015-06-26 30-day Notice
S067 2015-06-09 30-day Notice
S066 2015-05-06 30-day Notice
S065 2015-05-01 135 Review Track For 30-day Notice
S064 2015-04-09 30-day Notice
S063 2015-04-02 30-day Notice
S062 2015-03-27 135 Review Track For 30-day Notice
S061 2015-03-09 30-day Notice
S060 2015-03-04 30-day Notice
S059 2014-08-04 30-day Notice
S058 2014-07-28 30-day Notice
S057 2014-07-23 30-day Notice
S056 2014-07-23 30-day Notice
S055 2014-06-13 135 Review Track For 30-day Notice
S054 2014-05-23 30-day Notice
S053 2014-04-11 30-day Notice
S052 2014-04-09 Normal 180 Day Track
S051 2014-02-21 30-day Notice
S050 2014-01-09 135 Review Track For 30-day Notice
S049 2013-12-02 Panel Track
S048 2013-11-22 30-day Notice
S047 2013-11-13 30-day Notice
S046 2013-10-31 30-day Notice
S045 2013-10-17 135 Review Track For 30-day Notice
S044 2013-09-25 30-day Notice
S043 2013-08-21 30-day Notice
S042 2013-08-20 30-day Notice
S041 2013-06-20 30-day Notice
S040 2013-05-08 30-day Notice
S039 2013-03-25 30-day Notice
S038 2013-01-31 30-day Notice
S037 2012-09-20 30-day Notice
S036 2012-07-20 Real-time Process
S035 2012-03-06 135 Review Track For 30-day Notice
S034 2011-12-22 135 Review Track For 30-day Notice
S033 2011-06-08 30-day Notice
S032 2011-06-02 Real-time Process
S031 2011-03-30 Normal 180 Day Track No User Fee
S030 2011-01-12 Normal 180 Day Track No User Fee
S029 2011-01-11 Normal 180 Day Track No User Fee
S028 2010-11-22 30-day Notice
S027 2010-07-02 Normal 180 Day Track
S026 2010-05-17 135 Review Track For 30-day Notice
S025 2010-02-12 30-day Notice
S024 2009-10-06 30-day Notice
S023
S022 2009-02-06 30-day Notice
S021 2009-02-05 30-day Notice
S020 2009-01-29 Real-time Process
S019 2009-01-14 Normal 180 Day Track
S018 2008-12-09 Real-time Process
S017 2008-12-08 30-day Notice
S016 2008-11-06 30-day Notice
S015 2008-10-21 30-day Notice
S014 2008-10-16 30-day Notice
S013 2008-10-01 30-day Notice
S012 2008-08-04 30-day Notice
S011
S010 2008-06-30 30-day Notice
S009 2008-06-11 30-day Notice
S008
S007 2008-01-28 30-day Notice
S006 2007-12-26 Real-time Process
S005 2007-11-20 135 Review Track For 30-day Notice
S004 2007-05-18 Normal 180 Day Track
S003 2007-05-16 30-day Notice
S002 2007-04-18 30-day Notice
S001

NIH GUDID Devices

Device IDPMASupp
03770034301097 P050052 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.